Stock PD2 PATTERSON COMPANIES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Patterson Companies, Inc. Deutsche Boerse AG

Equities

PD2

US7033951036

Real-time Estimate Tradegate
Other stock markets
 04:17:48 2024-07-16 am EDT 		5-day change 1st Jan Change
22.7 EUR +1.34% Intraday chart for Patterson Companies, Inc. +2.75% -6.61%
Jul. 09 Evercore ISI Cuts Price Target on Patterson Companies to $25 From $27, Maintains In-Line Rating MT
Jun. 20 Morgan Stanley Adjusts Price Target on Patterson Companies to $28 From $30, Maintains Equalweight Rating MT

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
  • The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

  • The company shows low valuation levels, with an enterprise value at 0.39 times its sales.
  • The company has a low valuation given the cash flows generated by its activity.
  • Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
  • Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.

Weaknesses

  • With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
  • The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
  • The company sustains low margins.
  • Over the past four months, analysts' average price target has been revised downwards significantly.

Ratings chart - Surperformance

Sector: Medical Equipment, Supplies & Distribution

1st Jan change Capi. Investor Rating ESG Refinitiv
PATTERSON COMPANIES, INC. Stock Patterson Companies, Inc.
-6.61% 2.17B -
ABBOTT LABORATORIES Stock Abbott Laboratories
-6.46% 179B
C+
MEDTRONIC PLC Stock Medtronic plc
-6.43% 98.84B
C
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-7.28% 65.34B
A
HOYA CORPORATION Stock Hoya Corporation
+15.46% 45.41B
B+
DEXCOM, INC. Stock DexCom, Inc.
-8.93% 44.94B
B-
CENCORA, INC. Stock Cencora, Inc.
+8.19% 43.76B
B-
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+12.00% 29.01B
B
TERUMO CORPORATION Stock Terumo Corporation
+19.39% 25.65B
A-
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
-9.09% 23.32B
A-
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. PDCO Stock
  4. PD2 Stock
  5. Ratings Patterson Companies, Inc.